Board approved delayed unaudited standalone and consolidated financial results for Q1, Q2, and Q3 of FY2025-26 on April 17, 2026.
Q3 FY25 standalone revenue surged to ₹723.31 crore with a profit of ₹4.20 crore, a significant recovery from prior quarter losses.
Company is implementing an NCLT-approved resolution plan involving complete extinguishment of existing equity shares without payment to shareholders.
New management is streamlining regulatory compliance after a delay caused by the corporate insolvency resolution process concluded in December 2024.